Dr Gaia Coppock comments on how collaborative care among nephrologists is transforming glomerular disease treatment.

Dr Gaia Coppock examines approaches to guide colleagues and patients through the quickly changing landscape of IgA ...

In the past week, Wolfe Research upgraded Vertex Pharmaceuticals from “Peer Perform” to “Outperform,” citing growing ...

Vera Therapeutics received priority review from the FDA for its biologics license application for atacicept to treat adults ...

Atacicept is a recombinant fusion protein that binds to and inhibits the activity of BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand).

FDA assigned PDUFA target action date of July 7, 2026.If approved, atacicept would be the first B cell modulator targeting ...

Nephropathy is a broad medical term used to denote disease or damage of the kidney, which can eventually result in kidney failure. The primary and most obvious functions of the kidney are to excrete ...

What Happened? Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 3.8% in the afternoon session after ...

Dr Dana Rizk is Professor of Medicine in the Division of Nephrology at the University of Alabama at Birmingham (UAB) and a VOYXACT VISIONARY Study Investigator and Co-Chair of the Steering Committee.

New kidney treatment techniques achieved impressive results in some studies, with one method showing 71% kidney recovery ...

MicroRNAs (miRNAs) might have important roles in the pathogenesis and progression of IgA nephropathy Abnormal expression of miR-148b in peripheral blood mononuclear cells might account for the ...